Search company, investor...

Thios Pharmaceuticals

Founded Year

2000

Stage

Series A | Alive

Total Raised

$15M

Last Raised

$15M | 21 yrs ago

About Thios Pharmaceuticals

Thios Pharmaceuticals is a Healthcare/Pharmaceuticals / Drugs company based in Emeryville, California. Thios Pharmaceuticals' investors include Skyline Ventures and HealthCare Ventures.

Headquarters Location

5980 Horton Street Suite 400

Emeryville, California, 94608,

United States

510-420-6700

Missing: Thios Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Thios Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Thios Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was Thios Pharmaceuticals founded?

    Thios Pharmaceuticals was founded in 2000.

  • Where is Thios Pharmaceuticals's headquarters?

    Thios Pharmaceuticals's headquarters is located at 5980 Horton Street, Emeryville.

  • What is Thios Pharmaceuticals's latest funding round?

    Thios Pharmaceuticals's latest funding round is Series A.

  • How much did Thios Pharmaceuticals raise?

    Thios Pharmaceuticals raised a total of $15M.

  • Who are the investors of Thios Pharmaceuticals?

    Investors of Thios Pharmaceuticals include Skyline Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.